Skip to content

Vitamin A Kinetics and Mathematical Modeling in American Women

Vitamin A Kinetics and Mathematical Modeling in American Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03248700
Enrollment
8
Registered
2017-08-14
Start date
2008-03-31
Completion date
2016-10-31
Last updated
2019-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin A Kinetics

Brief summary

Women were given a vitamin A tracer, and blood was sampled to determine individual and group vitamin A kinetics. Data were subsequently modeled using compartmental analysis to determine effects of study length on model outcomes.

Detailed description

This is a longitudinal study in which American women were given an oral, stable isotope tracer of vitamin A, and blood was sampled in a staggered, serial design to determine individual and group vitamin A kinetics. Data were subsequently modeled using compartmental analysis, and study truncation analysis was performed on data to investigate the factor of study duration on resulting vitamin A kinetic models and outputs related to vitamin A metabolism.

Interventions

OTHERVitamin A tracer

A stable isotope tracer of vitamin A was given orally.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI (18.5 - 24.9 kg/m2)

Exclusion criteria

* Smoker * Pregnant * Trying to become pregnant * Lactating * Weight loss \> 4.5 kg during the past 3 months. * Actively trying to lose weight * Inability to refrain from drinking alcohol when requested * Amenorrhea * Acute or chronic illness including hepatitis * Current or previous history of anorexia or bulimia * Concurrent participation in other studies * Family member already enrolled in the study

Design outcomes

Primary

MeasureTime frameDescription
Total traced vitamin A massBaseline through 152 daysTotal amount of endogenous vitamin A determined by mathematical model, (µmol).

Secondary

MeasureTime frameDescription
Compartmental model complexityBaseline through 152 daysRequired number of compartments in mathematical model needed to adequately fit data.
Compartmental model fractional transfer coefficientsBaseline through 152 daysModel parameters adjusted to fit analytical data. Represents the fractional transfer from one compartment to another in the model, (pools/d, represented as L(i,j), the fraction of compartment J transferred to compartment I per day).
Serum vitamin A half-lifeBaseline through 152 daysHalf-life of vitamin A in serum, (d).
Vitamin A equilibration time and partitioningBaseline through 152 daysTime taken for vitamin A to equilibrate with body stores, (d).
Vitamin A tracer partitioningBaseline through 152 daysBody partitioning of tracer between serum and extravascular compartment(s), relative to total tracee mass. Calculated as a ratio of tracer-to-tracee ratio (TTR) in serum and extravascular stores, (TTR serum / TTR stores).
Vitamin A dietary intakeBaselineVitamin A dietary intake by food frequency questionnaire, (µg retinol activity equivalents/d).
Vitamin A disposal rateBaseline through 152 daysDaily loss or utilization of vitamin A, (µmol/d).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026